Publicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria de Navarra (8)

2022

  1. Activation of the unfolded protein response (Upr) is associated with cholangiocellular injury, fibrosis and carcinogenesis in an experimental model of fibropolycystic liver disease

    Cancers, Vol. 14, Núm. 1

  2. Messenger RNA as a personalized therapy: The moment of truth for rare metabolic diseases

    International Review of Cell and Molecular Biology (Elsevier Inc.), pp. 55-96

  3. New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin-6 production in tumor cells and KRAS co-opted epigenetic mediators driving metabolic reprogramming

    Journal of Experimental and Clinical Cancer Research, Vol. 41, Núm. 1

2020

  1. AGAP2: Modulating TGFβ1-signaling in the regulation of liver fibrosis

    International Journal of Molecular Sciences, Vol. 21, Núm. 4

  2. Pilot multi-omic analysis of human bile from benign and malignant biliary strictures: A machine-learning approach

    Cancers, Vol. 12, Núm. 6, pp. 1-30

2019

  1. Dual Targeting of Histone Methyltransferase G9a and DNA-Methyltransferase 1 for the Treatment of Experimental Hepatocellular Carcinoma

    Hepatology, Vol. 69, Núm. 2, pp. 587-603

  2. Role of AGAP2 in the profibrogenic effects induced by TGFβ in LX-2 hepatic stellate cells

    Biochimica et Biophysica Acta - Molecular Cell Research, Vol. 1866, Núm. 4, pp. 673-685

2018

  1. NADPH oxidase 5 promotes proliferation and fibrosis in human hepatic stellate cells

    Free Radical Biology and Medicine, Vol. 126, pp. 15-26